7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Psychologic depression is a pivotal pathological characteristic and has been shown to promote prostate cancer (PCa) progression. Chaihu-Shugan-San (CSS), a well-known Chinese herbal decoction, exhibits efficacy in the treatment of stress-accelerated PCa. However, the underlying mechanism of CSS in resisting PCa growth is still unknown, and further study is needed.

          Objective: To evaluate the effects of CSS on stress-accelerated PCa in a BALB/C nude mice model and to investigate the underlying mechanisms.

          Methods: PC-3 cells were implanted into BALB/C nude mice, and the stressed mice were exposed to chronic unpredictable mild stress (CUMS) to study the effects of CSS. The PCa growth were evaluated by tumor volume and tumor weight. Analyses of depression-like behaviors were evaluated by sucrose consumption test, tail suspension test and open field test. Network pharmacology was used to analyze the potential targets and signaling pathways of CSS against PCa. Untargeted lipidomics were used to analyze the serum lipid profiles and further elucidate the possible mechanism.

          Results: In the CUMS stressed PCa mice, CSS can restrain tumor growth with reduced tumor volume and tumor weight, and depression-like behaviors with increased sucrose consumption, reduced immobility duration, and increased total distance and center distance. Network pharmacology suggested that the lipid metabolism-related pathways are the most likely potential targets of CSS against PCa. Using untargeted lipidomics analysis, 62 lipids were found to have significant changes in PCa mice under CUMS treatment. The levels of glycerophospholipids containing phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and phosphatidylglycerol (PG), except PC (18:0_22:6) and PC (18:0_20:4), were significantly increased. Likewise, the levels of all sphingolipids (including sphingomyelin (SM), ceramides (Cer) and hexosyl-1-ceramide (Hex1Cer)) and diglyceride (DG) (32:1e) were significantly increased. CSS water extract was found to contribute to restore 32 lipids including 6 sphingolipids, 25 glycerophospholipids and 1 glyceride.

          Conclusion: This study is the first to delineate the lipid profile of stressed PCa BALB/C nude mice using untargeted lipidomics analysis. CSS restrained tumor growth and ameliorated depression-like behaviors by reprogramming lipid metabolism. Intervention of lipid metabolism could be a preventive and therapeutic approach for PCa patients with depression.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: found

          Metabolic pathways promoting cancer cell survival and growth.

          Activation of oncogenes and loss of tumour suppressors promote metabolic reprogramming in cancer, resulting in enhanced nutrient uptake to supply energetic and biosynthetic pathways. However, nutrient limitations within solid tumours may require that malignant cells exhibit metabolic flexibility to sustain growth and survival. Here, we highlight these adaptive mechanisms and also discuss emerging approaches to probe tumour metabolism in vivo and their potential to expand the metabolic repertoire of malignant cells even further.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer

              Altered lipid metabolism is among the most prominent metabolic alterations in cancer. Enhanced synthesis or uptake of lipids contributes to rapid cancer cell growth and tumor formation. Lipids are a highly complex group of biomolecules that not only constitute the structural basis of biological membranes but also function as signaling molecules and an energy source. Here, we summarize recent evidence implicating altered lipid metabolism in different aspects of the cancer phenotype and discuss potential strategies by which targeting lipid metabolism could provide a therapeutic window for cancer treatment.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                05 December 2022
                2022
                : 13
                : 1011450
                Affiliations
                [1] 1 Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica , School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing, China
                [2] 2 Institute of TCM-Related Comorbid Depression , School of Chinese Medicine , School of Integrated Chinese and Western Medicine , Nanjing University of Chinese Medicine , Nanjing, China
                [3] 3 School of Medicine and Holistic Medicine , Nanjing University of Chinese Medicine , Nanjing, China
                [4] 4 Department of Pharmacy , The Affiliated Suzhou Hospital of Nanjing Medical University , Suzhou Municipal Hospital , Suzhou, China
                Author notes

                Edited by: Rosy Iara Maciel De Azambuja Ribeiro, Universidade Federal de São João del-Rei, Brazil

                Reviewed by: Zeeshan Fatima, Amity University Gurgaon, India

                Xiangjun Qiu, Henan University of Science and Technology, China

                *Correspondence: Ruini Chen, ruini2007@ 123456njucm.edu.cn

                This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

                Article
                1011450
                10.3389/fphar.2022.1011450
                9760688
                36545317
                10592979-6966-4db1-8864-611798fadd55
                Copyright © 2022 Li, Zhou, Zheng, Sun, Jin, Hong and Chen.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 04 August 2022
                : 24 November 2022
                Funding
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Funded by: Natural Science Foundation of Jiangsu Province , doi 10.13039/501100004608;
                Categories
                Pharmacology
                Original Research

                Pharmacology & Pharmaceutical medicine
                chaihu-shugan-san,prostate cancer,depression,sphingolipid,glycerinphospholipid

                Comments

                Comment on this article